ClinicalTrials.gg
Not yet recruitingNCT04591860Updated Apr 2, 2024

A Prospective Randomised Multi - Center Trial on the Repair of Large Hiatal Hernias: Absorbable Mesh vs. Pledgeted Sutures vs. Sutures Only

An interventional study of Laparoscopic or robot-assisted hiatal closure (sutures only vs. absorbable mesh vs. pledgeted sutures) and fundoplication according to Toupet in Hiatal Hernia, sponsored by Paracelsus Medical University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-02.

Sponsored by Paracelsus Medical University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
165
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A prospective randomised multi - center trial on the repair of large hiatal hernias with sutures versus pledgeted sutures versus absorbable mesh

The primary objective of the present trial is to compare the hiatal hernia recurrence rate between three different methods of cruroplasty in large hiatal hernias: hiatal closure with sutures versus pledgeted sutures versus absorbable mesh (Phasix™ST mesh).

The duration of the study is not limited and depends on the number of cases planned. After enrollment in the study, patients will be followed - up with standardized questionnaires and gastroscopy at 6 months, 1 year, 3 years and 5 years after surgery.

02

Conditions studied

  • Hiatal Hernia

Browse trials for

Keywords

  • hiatal hernia
  • pledgets
  • mesh
  • hernia recurrence
03

In context

Hernia, Hiatal

87 studies on the registry are indexed under Hernia, Hiatal; 27 are open to participants now.

This study's planned enrollment of 165 is above the median of 100 across 56 interventional studies indexed under Hernia, Hiatal.

Browse Hernia, Hiatal studies →

Lead sponsor

Paracelsus Medical University is the lead sponsor of 33 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a large hiatal hernia - admitted for surgery (laparoscopic / robot-assisted)
  • Written
  • ≥ 18 years of age
  • Hiatal hernia documented by barium x-ray and/or gastroscopy and/or manometry by one or more of the following criteria:

    • > 5cm hiatal hernia
    • 1/3 of the stomach in the thorax

Exclusion criteria

Exclusion Criteria:

  • Lack of patient consent for study participation
  • Lack of consent to study due to linguistic or mental incomprehension
  • Patients in poor general condition (lack of anesthesia ability)
  • Pregnancy
  • Prior surgery on the stomach or gastroesophageal junction
  • Simultaneous surgery because of another illness
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
165 participants (estimated)

Study arms

  • Active comparator
    Sutures only

    Patients with a large hiatal hernia undergo the cruroplasty with sutures only. A large hiatal hernia is defined as \> 5cm in manometry or gastroscopy or at least 1/3 of the stomach lying intrathoracically.

    Device: Laparoscopic or robot-assisted hiatal closure (sutures only vs. absorbable mesh vs. pledgeted sutures) and fundoplication according to Toupet

  • Active comparator
    Absorbable Mesh

    Patients with a large hiatal hernia undergo the cruroplasty with mesh implantation. A large hiatal hernia is defined as \> 5cm in manometry or gastroscopy or at least 1/3 of the stomach lying intrathoracically.

    Device: Laparoscopic or robot-assisted hiatal closure (sutures only vs. absorbable mesh vs. pledgeted sutures) and fundoplication according to Toupet

  • Active comparator
    Pledgeted sutures

    Patients with a large hiatal hernia undergo the cruroplasty with pledgeted sutures. A large hiatal hernia is defined as \> 5cm in manometry or gastroscopy or at least 1/3 of the stomach lying intrathoracically.

    Device: Laparoscopic or robot-assisted hiatal closure (sutures only vs. absorbable mesh vs. pledgeted sutures) and fundoplication according to Toupet

Interventions

  • DeviceLaparoscopic or robot-assisted hiatal closure (sutures only vs. absorbable mesh vs. pledgeted sutures) and fundoplication according to Toupet

    Patients are scheduled to undergo laparoscopic or robot-assisted surgery for a large symptomatic hiatal hernia.The hiatal closure will be done with sutures, pledgeted sutures or absorbable mesh (Phasix™ST mesh). After cruroplasty a fundoplication according to Toupet will be done additionally.

06

What researchers measure

Primary outcomes

  1. Hiatal hernia recurrence rate

    Hiatal hernia recurrence rate documented by gastroscopy

    Time frame: 6 months, 1 year, 3 years and 5 years after surgery

Secondary outcomes

  1. Quality of Life evaluated by questionnaire

    Quality of Life measured by Gastrointestinal Quality of Life Index (GIQLI)

    Time frame: Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery

  2. Symptoms related to Gastroesophageal Reflux Disease (GERD)

    Typical and atypical GERD symptoms assessed by the Symptom Check List (SCL) in units of a scale.

    Time frame: Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery

  3. Primary extraesophageal GERD symptoms related to Gastroesophageal Reflux Disease (GERD)

    Primary atypical GERD symptoms assessed by the Reflux Symptom Index (RSI - Score) in units of a scale

    Time frame: Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery

  4. Postoperative complications

    Short - term and long - term complications after treatment

    Time frame: 6 months, 1 year, 3 years and 5 years after surgery

  5. Length of hospital stay

    Length of hospital stay and mortality rates

    Time frame: up to 90 days

  6. Predictive parameters for treatment response or failure I

    Weight (in kilograms)

    Time frame: Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery

  7. Predictive parameters for treatment response or failure II

    Height (in meters)

    Time frame: Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Koch O, von Rahden BHA, Wykypiel H, Schoppmann SF, Fugger R, Rosanelli G, Emmanuel K, Weitzendorfer M. [Planning and Design of a Prospective Randomised Multi-Centre Trial on the Repair of Large Hiatal Hernias with Sutures vs. Pledgeted Sutures vs. Absorbable Mesh]. Zentralbl Chir. 2021 Apr;146(2):204-209. doi: 10.1055/a-1369-9694. Epub 2021 Feb 10. German. PubMed 33567462 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04591860
Lead sponsor
Paracelsus Medical University
Collaborators
Medical University Innsbruck, Medical University of Vienna, Krankenhaus Barmherzige Schwestern Linz, Elisabethinen Hospital
Responsible party
Michael Weitzendorfer, MD (Dr. Michael Weitzendorfer, PhD, Paracelsus Medical University) — Principal investigator
First posted
Oct 19, 2020
Start date
May 1, 2024 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Apr 2, 2024

Study contacts

Michael Weitzendorfer, MD, PhD
Contact
m.weitzendorfer@salk.at
+435725551078
Oliver O Koch, MD, FEBS
Contact
o.koch@salk.at
+435725551091

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion